Unplanned Early Readmissions of Hospitalized Patients with Cirrhosis
住院肝硬化患者的意外提前再入院
基本信息
- 批准号:10384144
- 负责人:
- 金额:$ 9.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:Active LearningAscitesAwardBehavioralBiometryCaregiver BurdenCaringCharacteristicsCirrhosisClinical ResearchClinical SciencesClinical TrialsCognitiveConsensusDataData AnalysesDevelopment PlansDiseaseEligibility DeterminationEnrollmentEnvironmentExtramural ActivitiesFosteringFundingFutureGastrointestinal HemorrhageGoalsGrowth and Development functionHealthHealth Care Quality IndicatorsHealth PrioritiesHealth Services ResearchHealthcare SystemsHepatic EncephalopathyHepatologyHospice CareHospitalizationHospitalsIncidenceIndianaInfectionInformation NetworksInstitutesInterventionIntervention StudiesLeadLiver CirrhosisLiver diseasesMentorsMentorshipMethodologyMethodsModelingOutcomePalliative CarePatientsPhysiciansPopulationPositioning AttributeProcessProspective cohortProspective cohort studyPsychologyPublic HealthQualitative ResearchResearchResearch PersonnelResourcesRisk FactorsScientistSenior ScientistSeverity of illnessSocial WorkSpecialistStructureTranslational ResearchTransplantationTransplantation SurgeryUniversitiesValidationcare outcomescareercareer developmentcostcost estimatedesigneffective interventionend stage diseasefollow-uphigh riskhigh risk populationhospice environmenthospital readmissionimplementation scienceimprovedinnovationliver transplantationmodifiable riskmortalitymulti-component interventionmultidisciplinarypatient orientedpatient oriented researchpatient stratificationpredictive modelingprogramsprospectiveresearch and developmentrisk stratificationskillssocial factorstime use
项目摘要
PROJECT SUMMARY
Patients with liver cirrhosis who are discharged from the hospital have high rates of early hospital readmission,
and these readmissions are a significant burden to the health care system. Reducing readmissions is a priority
for the health care system, but requires a thorough understanding of modifiable risk factors leading to
readmission. In addition, many patients who are readmitted to the hospital may benefit from hospice referral,
which is underutilized in patients with cirrhosis, and which may also reduce readmissions. This proposal
describes a career development plan that will enable the candidate to develop expertise in patient-oriented
clinical research by acquiring the necessary skills in health services research, implementation science,
palliative care, and biostatistics. The specific aims are to (1) determine the incidence and predictors of
unplanned 30 day readmissions in patients with cirrhosis; (2) identify factors associated with preventable
unplanned 30 day readmissions; and (3) develop criteria that identify hospitalized patients with cirrhosis who
are suitable for hospice care. To achieve these aims, the candidate will (1) study detailed multidimensional
characteristics of a large prospective cohort of hospitalized patients with cirrhosis; (2) systematically assess
readmission preventability; and (3) convene an expert panel using the modified Delphi consensus process to
identify criteria for hospice eligibility.
The proposed career development plan integrates: close mentoring from a multidisciplinary team of senior
scientists; advanced coursework in health services research, biostatistics, implementation science, and
qualitative research; experiential learning through the conduct of the proposed research plan; and a highly
supportive research environment. The mentorship team, which includes independent investigators with
expertise in clinical and translational research in hepatology (Chalasani), health services research and
implementation science (Boustani), palliative care and consensus methodology (Sachs), and observational and
longitudinal data analysis and biostatistics (Gao), will guide the candidate's research and career development.
The research environment at Indiana University includes multidisciplinary collaborative organizations such as
the Indiana Clinical and Translational Sciences Institute and the Center for Health Innovation and
Implementation Science, which will help foster the candidate's professional growth and career development. At
the conclusion of this program, the candidate will be well positioned to become an independent physician-
scientist conducting high quality health services research in cirrhosis.
项目概要
肝硬化出院患者早期再入院率较高,
这些重新入院对医疗保健系统来说是一个沉重的负担。减少再入院是当务之急
对于医疗保健系统来说,但需要彻底了解可改变的风险因素,从而导致
重新入院。此外,许多重新入院的患者可能会受益于临终关怀转诊,
它在肝硬化患者中未得到充分利用,也可能减少再入院率。这个提议
描述了一个职业发展计划,该计划将使候选人能够发展以患者为中心的专业知识
通过获得卫生服务研究、实施科学、
姑息治疗和生物统计学。具体目标是 (1) 确定以下情况的发生率和预测因素:
肝硬化患者 30 天计划外再入院; (2) 识别与可预防相关的因素
30 天计划外再入院; (3) 制定标准来识别住院的肝硬化患者
适合临终关怀。为了实现这些目标,候选人将(1)研究详细的多维
肝硬化住院患者的大型前瞻性队列的特征; (2)系统评估
可预防再入院; (3) 使用修改后的德尔菲共识流程召集专家小组,以
确定临终关怀资格的标准。
拟议的职业发展计划包括: 来自多学科高级团队的密切指导
科学家;卫生服务研究、生物统计学、实施科学等方面的高级课程
定性研究;通过实施拟议的研究计划进行体验式学习;和一个高度
支持性的研究环境。指导团队包括独立调查员
肝病学(Chalasani)临床和转化研究、卫生服务研究和
实施科学(布斯塔尼)、姑息治疗和共识方法(萨克斯)以及观察和
纵向数据分析和生物统计学(高),将指导候选人的研究和职业发展。
印第安纳大学的研究环境包括多学科合作组织,例如
印第安纳临床与转化科学研究所和健康创新中心
实施科学,这将有助于促进候选人的专业成长和职业发展。在
该计划结束后,候选人将有能力成为一名独立医生-
科学家对肝硬化进行高质量的卫生服务研究。
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A dedicated paracentesis clinic decreases healthcare utilization for serial paracenteses in decompensated cirrhosis.
专门的穿刺诊所减少了失代偿性肝硬化患者连续穿刺的医疗保健利用率。
- DOI:
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Cheng, Yao;Sandrasegaran, Kumar;Cheng, Katherine;Shah, Angela;Ghabril, Marwan;Berry, William;Lammert, Craig;Chalasani, Naga;Orman, Eric S
- 通讯作者:Orman, Eric S
Development and Validation of a Model to Predict Acute Kidney Injury in Hospitalized Patients With Cirrhosis.
预测住院肝硬化患者急性肾损伤的模型的开发和验证。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Patidar, Kavish R;Xu, Chenjia;Shamseddeen, Hani;Cheng, Yao;Ghabril, Marwan S;Mukthinuthalapati, V V Pavan K;Fricker, Zachary P;Akinyeye, Samuel;Nephew, Lauren D;Desai, Archita P;Anderson, Melissa;El;Chalasani, Naga P;Orman
- 通讯作者:Orman
Palliative Care and Hospice Referrals in Patients with Decompensated Cirrhosis: What Factors Are Important?
失代偿性肝硬化患者的姑息治疗和临终关怀转诊:哪些因素很重要?
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:2.8
- 作者:Holden, John H;Shamseddeen, Hani;Johnson, Amy W;Byriel, Benjamin;Subramoney, Kavitha;Cheng, Yao;Saito, Akira;Ghabril, Marwan;Chalasani, Naga;Sachs, Greg A;Orman, Eric S
- 通讯作者:Orman, Eric S
Bleeding After Elective Interventional Endoscopic Procedures in a Large Cohort of Patients With Cirrhosis.
一大群肝硬化患者选择性介入内窥镜手术后出血。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Kundumadam, Shanker;Phatharacharukul, Parkpoom;Reinhart, Kathryn;Yousef, Andrew;Shamseddeen, Hani;Pike, Francis;Patidar, Kavish R;Gromski, Mark;Chalasani, Naga;Orman, Eric S
- 通讯作者:Orman, Eric S
Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.
新诊断肝硬化患者的特征、死亡率和其他结果的趋势。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:13.8
- 作者:Orman, Eric S;Roberts, Anna;Ghabril, Marwan;Nephew, Lauren;Desai, Archita P;Patidar, Kavish;Chalasani, Naga
- 通讯作者:Chalasani, Naga
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric Orman其他文献
Eric Orman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric Orman', 18)}}的其他基金
The Transitional Liver Clinic (TLC): Reducing Liver Disease Readmission
过渡肝脏诊所 (TLC):减少肝病再入院
- 批准号:
10587530 - 财政年份:2023
- 资助金额:
$ 9.01万 - 项目类别:
The Cirrhosis Medical Home: A Feasibility Study
肝硬化医疗之家:可行性研究
- 批准号:
10202587 - 财政年份:2020
- 资助金额:
$ 9.01万 - 项目类别:
Unplanned Early Readmissions of Hospitalized Patients with Cirrhosis
住院肝硬化患者的意外提前再入院
- 批准号:
9353422 - 财政年份:2016
- 资助金额:
$ 9.01万 - 项目类别:
Unplanned Early Readmissions of Hospitalized Patients with Cirrhosis
住院肝硬化患者的意外提前再入院
- 批准号:
9767124 - 财政年份:2016
- 资助金额:
$ 9.01万 - 项目类别:
相似国自然基金
去泛素化酶UCHL1稳定KLF4调控卵巢癌腹水多细胞簇干性
- 批准号:82303542
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
腹水油酸-LUM通路介导卵巢癌铂耐药促进CD8+T细胞衰老的机制研究
- 批准号:82372888
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
KAT14介导PFKFB3乙酰化修饰抑制腹水来源ALDH+CD44+卵巢癌细胞干性的机制研究
- 批准号:82303547
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于超分子自组装技术探讨“十八反”药对芫花-甘草治疗肝癌腹水的物质基础及作用机制
- 批准号:82204600
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
腹水微环境诱导卵巢癌细胞PD-1表达的功能及机制研究
- 批准号:82273315
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Targeting chemotherapy resistant high grade serous ovarian cancer
靶向化疗耐药的高级别浆液性卵巢癌
- 批准号:
10744479 - 财政年份:2023
- 资助金额:
$ 9.01万 - 项目类别:
Identifying determinants of access to the early steps of liver transplant in the Southeast
确定东南部获得肝移植早期步骤的决定因素
- 批准号:
10644293 - 财政年份:2023
- 资助金额:
$ 9.01万 - 项目类别:
Defining Phenotypes of Alcohol-Associated Liver Disease with Acute Hepatic Decompensation
定义酒精相关性肝病急性肝功能失代偿的表型
- 批准号:
10424443 - 财政年份:2021
- 资助金额:
$ 9.01万 - 项目类别: